![]() |
|
|
| INTRODUCTION |
|---|
|
|
|---|
The isoflavone content of soy milk and soy germ used in this
study was calculated according to isoflavone extinction coefficients
and normalized to the total daidzein, genistein and glycitein
calculated as aglycone isoflavones. Due to re-purification and
recent commercial availability, the extinction coefficients of
acetylgenistein and acetyldaidzein were re-evaluated. The new
extinction coefficients for these two compounds were different from
those previously used (Acetyldaidzin: old
= 16331 [Ohta et al. 1979
]; new
= 29007. Acetylgenistin: old
= 18197 [Ohta et al. 1980
]; new
= 38946). The new molar extinction coefficients were
evaluated after isolating acetyldaidzin and acetylgenistin from
soybeans (Wang and Murphy 1994
). These extinction coefficients were
compared with and agreed closely with extinction coefficients derived
from acetyl standards generously donated by LC Laboratories, [Woburn,
MA]. Minimal differences were found between the acetylglycitin
extinction coefficients determined in our laboratory and the published
values (Kudou et al. 1991
). According to these new data, the isoflavone
contents of the soygerm and soymilk used in this feeding study were
overestimated in the original paper. The recalculated isoflavone
contents in both soy milk and soygerm powders are shown in Table 1
. Urinary isoflavone excretion as a
percentage of ingested dose was recalculated accordingly. Because there
was no difference in urinary excretion as percentage of ingested dose
according to the soy food administered, as reported previously,
combined data are shown in Table 2
. Total urinary excretion of daidzein (52.4%) was slightly greater than
that of glycitein (46.7%), but there was no significant difference
between them (p = 0.08). Both daidzein and glycitein excretion
were significantly greater than that of genistein (37.0%) (p = 0.004 and p = 0.01 respectively). Female subjects excreted
slightly greater amounts of all three compounds at each time point than
did male subjects (p = 0.03). The overall urinary excretion as
percentage of ingested dose (total over 48 h) of daidzein,
genistein and glycitein were 57.4, 42.3 and 50.2% in females, and
48.8, 36.4, and 42.1% in males, respectively. Based on these new data,
the urinary disposition of the three main isoflavones showed that more
daidzein and glycitein were excreted than was genistein, and daidzein
and glycitein excretions were similar. This disposition pattern was
different from that reported originally (glycitein greater than daidzein, Zhang et al. 1999
). On reverse phase HPLC analysis, daidzein
and glycitein appeared earlier than genistein (by more than 5 min), and
glycitein was eluted about 1 min later than was daidzein. These HPLC
results showed that daidzein and glycitein had similar hydrophobicity
and that they were more hydrophilic than was genistein. The absence of
the 5-OH group makes both daidzein and glycitein more hydrophilic than
genistein. The 5-OH forms part of an internal hydrogen bond that makes
genistein more hydrophobic although it contains more free hydroxyls
than glycitein or daidzein. The absence of the 5-OH probably makes
daidzein and glycitein less susceptible to microbial breakdown than is
genistein (Griffiths and Smith, 1972
). The newly calculated urinary
disposition of the isoflavones may be explained by their structural
properties, genistein being less bioavailable as reflected in urinary
excretion because of its greater susceptibility to microbial breakdown
than either daidzein or glycitein. Compared with daidzein, genistein
has been shown to be more susceptible to breakdown by gut
microorganisms during anaerobic incubations of human fecal samples (Xu et al. 1995
). But glycitein metabolism by gut microflora is not yet
known. Isoflavone bioavailability has only been compared between
genders in one other study. Lampe et al. (1998)
fed people with soy
protein containing 22 mg daidzein and 8 mg genistein for 4 days. They
did not find any differences in daily excretion of daidzein, genistein
and O-desmethylangolensin between equol excreters and nonexcreters
and between men and women. The slight gender differences in isoflavone
urinary excretion observed in this study are not readily explained and
need further study. Overall, our recalculation showed that daidzein and
glycitein had similar bioavailability and they were more bioavailable
than was genistein, based on urinary disposition.
|
|
| REFERENCES |
|---|
|
|
|---|
1. Griffiths L. A., Smith G. E. Metabolism of apigenin and related compounds in the rat. Biochem. J. 1972;128:901-911[Medline]
2. Kudou S., Shimoyamada M., Imura T., Uchida T., Okubo K. A new isoflavone glycoside in soybean seeds (Glycine max Merril), Glycitein-7-O-ß-D-(6'-O-acetyl)-glucopyranoside. Agric. Food Chem. 1991;55:859
3. Lampe J. W., Karr S. C., Hutchins A. M., Slavin J. L. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc. Soc. Exp. Biol. Med. 1998;217:335-339[Abstract]
4. Ohta N., Kuwata G., Akahori H., Watanabe T. Isoflavonoid constituents of soybeans and isolations of a new acetyl daidzein. Agric. Biol. Chem. 1979;43:1415
5. Ohta N., Kuwata G., Akohori H., Watanabe T. Isolations of a new isoflavone acetyl glucoside, 6''-O-acetyl genistin. Agric. Biol. Chem. 1980;44:469
6. Wang H.-J., Murphy P. A. Isoflavones of commercial soybean foods. J. Agric. Food Chem. 1994;42:1666-1673
7. Xu X., Harris K. S., Wang H.-J., Murphy P. A., Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 1995;125:2307-2315
8.
Zhang Y., Wang G.-J., Song T. T., Murphy P. A., Hendrich S. Differences in disposition of the soybean isoflavones, glycitein, daidzein and genistein in humans with moderate fecal isoflavone degradation activity. J. Nutr. 1999;129:957-962
| ||||||||||||||||||||||||||||||||||||||||||||